Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-MIBG with or without Vorinostat for Recurrent or Progressive Neuroblastoma
NCT03561259Phase 2Unknown
- Sponsor
- Jubilant DraxImage
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iobenguane I-131 in neuroblastoma, sponsored by Jubilant DraxImage. Status: unknown.
02
Drugs
Iobenguane I-131
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT03561259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03561259.